17 December 2021
Barkby Group PLC
("Barkby" or the "Company")
Exchange of Contracts in Swindon, Wiltshire
Barkby Group PLC (AIM:BARK), is pleased to announce that it has exchanged contracts on a property development site in Swindon, Wiltshire. The Company is now in legal negotiations with prospective tenants who will enter into pre-let agreements for occupation at completion of the development.
It is proposed that the Company will develop a 30,000 sq. ft. mixed-use retail and trade scheme at the site. Under the proposed development, the site has an estimated gross development value of £7.5 million.
This adds to existing proposed schemes at Wellingborough, Maldon, Huntingdon and Saffron Walden which the Company is currently developing. The Company is in advanced negotiations to add to its development pipeline and will be making further announcements shortly.
Charles Dickson, Executive Chairman of Barkby Group Plc, commented:
"I am delighted to have exchanged contracts for this site in Swindon, adding to our growing pipeline of commercial property developments. The site is well positioned and we are pleased that we are once again seeing strong demand from both the retail and employment sectors for new, well-located developments, despite the wider economic impact of the pandemic."
Enquiries:
Barkby Group plc Charles Dickson (Executive Chairman) Douglas Benzie (CFO)
| via Camarco | | |
finnCap Ltd (Nomad and Broker) Carl Holmes/Simon Hicks (corporate finance) Tim Redfern/Richard Chambers (ECM)
| +44 (0) 20 7220 0500 | ||
Camarco (Financial PR) Jennifer Renwick/Jake Thomas | +44 (0) 20 3757 4994 | ||
Notes to editors
Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include: Barkby Real Estate, Barkby Pub Co. and Barkby Investments (comprising of Workshop Coffee, Centurian Automotive, Cambridge Sleep Sciences and a minority stake in Verso Biosense).
Barkby's strategy is to accelerate and maximise opportunities within its existing businesses.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.